PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 61 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $10,344,000 | +1338.7% | 574,974 | +469.8% | 0.01% | +500.0% |
Q1 2020 | $719,000 | -70.7% | 100,900 | -1.7% | 0.00% | 0.0% |
Q4 2019 | $2,450,000 | -4.4% | 102,600 | +7.3% | 0.00% | -50.0% |
Q3 2019 | $2,564,000 | +0.7% | 95,600 | +1.9% | 0.00% | 0.0% |
Q2 2019 | $2,545,000 | -21.8% | 93,800 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $3,255,000 | +79.0% | 93,800 | +0.7% | 0.00% | +100.0% |
Q4 2018 | $1,818,000 | -27.7% | 93,135 | -1.3% | 0.00% | -50.0% |
Q3 2018 | $2,513,000 | -29.5% | 94,360 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $3,564,000 | -58.2% | 94,360 | -63.9% | 0.00% | -66.7% |
Q1 2018 | $8,536,000 | +129.6% | 261,360 | +242.3% | 0.01% | +100.0% |
Q4 2017 | $3,717,000 | -32.8% | 76,360 | -25.4% | 0.00% | -25.0% |
Q3 2017 | $5,531,000 | -6.3% | 102,370 | -2.6% | 0.00% | -20.0% |
Q2 2017 | $5,906,000 | -59.4% | 105,150 | -71.7% | 0.01% | -58.3% |
Q1 2017 | $14,554,000 | +89.5% | 371,373 | +8.5% | 0.01% | +100.0% |
Q4 2016 | $7,681,000 | -1.2% | 342,283 | 0.0% | 0.01% | -14.3% |
Q3 2016 | $7,773,000 | -3.8% | 342,283 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $8,078,000 | +15.7% | 342,283 | 0.0% | 0.01% | +16.7% |
Q1 2016 | $6,983,000 | -60.3% | 342,283 | 0.0% | 0.01% | -60.0% |
Q4 2015 | $17,610,000 | +20.7% | 342,283 | -0.0% | 0.02% | +15.4% |
Q3 2015 | $14,589,000 | -6.3% | 342,298 | +0.1% | 0.01% | 0.0% |
Q2 2015 | $15,570,000 | +24.1% | 341,823 | +3.4% | 0.01% | +30.0% |
Q1 2015 | $12,550,000 | +35.6% | 330,623 | +1.2% | 0.01% | +25.0% |
Q4 2014 | $9,256,000 | +12.0% | 326,823 | 0.0% | 0.01% | +14.3% |
Q3 2014 | $8,262,000 | -20.0% | 326,823 | -7.6% | 0.01% | -22.2% |
Q2 2014 | $10,322,000 | +17.4% | 353,723 | +4.2% | 0.01% | +12.5% |
Q1 2014 | $8,789,000 | -57.0% | 339,357 | -57.2% | 0.01% | -55.6% |
Q4 2013 | $20,416,000 | +3413.9% | 792,857 | +3548.0% | 0.02% | +1700.0% |
Q3 2013 | $581,000 | +110.5% | 21,734 | +93.3% | 0.00% | – |
Q2 2013 | $276,000 | – | 11,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |